PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 30 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
Used in formulas like Gansui Banxia decoction to treat abnormal accumulation of body fluids [PMID:40356964].
A single dose of 6g powder in humans showed potential for body weight loss; in mice, it attenuated insulin resistance and reduced liver/adipose tissue inflammation [PMID:29234441].
Extracts reactivated latent HIV in CD4+ T cell models and HIV+ HAART suppressed PBMC by inducing CD69 and P-TEFb [PMID:27977742].
Methanol extract effectively reduced acanthosis and inflammatory cell infiltration in an IMQ-induced mouse model [PMID:28761880].
Various constituents exhibited cytotoxicity against colon (HCT-116), gastric (MKN-45), and breast (MCF-7) cancer cell lines [PMID:29292735].
Safety & adverse effects
Drug interactions
Evidence summary
PubMed sources
- 1.PMID: 27080940 (2016) — The Chemical and Biological Properties of Euphorbia kansui. · The American journal of Chinese medicine
- 2.PMID: 27977742 (2016) — Euphorbia Kansui Reactivates Latent HIV. · PloS one
- 3.PMID: 29292735 (2017) — Chemical Constituents from Euphorbia kansui. · Molecules (Basel, Switzerland)
- 4.PMID: 31132752 (2019) — Hepatotoxicity evaluation of Euphorbia kansui on zebrafish larvae in vivo. · Phytomedicine : international journal of phytotherapy and phytopharmacology
- 5.PMID: 40356964 (2025) — Kansui-liquorice enhances the "water-expelling" effect of Gansui Banxia decoction in rats with malignant ascites by targeting the NPs/NPRs/cGMP/PKGⅡ pathway and T cell immunity.